Company intelligence / Profile preview

Yunkang Group

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Provides over 2,000 types of diagnostic testing items; launched 150+ new projects in recent reporting period. Operates 12 independent laboratories with ISO15189 and CAP certifications.

Therapeutic areas: OtherCardiovascularImmunologyEndocrinology
Industry: Pathology

Partnerships

Only execution partner of CLSI’s healthcare business in ChinaCollaborations with over 700 hospitals from more than 300 medical institution alliances

Beyond the preview

Go deeper on Yunkang Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunkang Group.

Explore the full profile